Nisa Investment Advisors’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $382 | Sell |
106
-175
| -62% | -$631 | ﹤0.01% | 2909 |
|
|
2025
Q1 | $840 | Buy |
281
+258
| +1,122% | +$771 | ﹤0.01% | 2682 |
|
|
2024
Q4 | $77 | Sell |
23
-105
| -82% | -$352 | ﹤0.01% | 2990 |
|
|
2024
Q3 | $429 | Sell |
128
-54
| -30% | -$181 | ﹤0.01% | 2748 |
|
|
2024
Q2 | $602 | Buy |
182
+159
| +691% | +$526 | ﹤0.01% | 2645 |
|
|
2024
Q1 | $93 | Hold |
23
| – | – | ﹤0.01% | 2716 |
|
|
2023
Q4 | $70 | Sell |
23
-6,644
| -100% | -$20.2K | ﹤0.01% | 2624 |
|
|
2023
Q3 | $20K | Buy |
6,667
+1,220
| +22% | +$3.66K | ﹤0.01% | 2017 |
|
|
2023
Q2 | $20.4K | Buy |
+5,447
| New | +$20.4K | ﹤0.01% | 2098 |
|
|
2023
Q1 | – | Sell |
-120
| Closed | -$1K | – | 2529 |
|
|
2022
Q4 | $1K | Buy |
+120
| New | +$1K | ﹤0.01% | 2395 |
|